S. Jern

发表

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.

M. Nieminen, P. Okin, R. Devereux, 2004, JAMA.

Platelets synthesize large amounts of active plasminogen activator inhibitor 1.

H. Brogren, D. Erlinge, S. Jern, 2004, Blood.

ST-segment changes and catecholamine-related myocardial enzyme release during alcohol withdrawal.

S. Jern, H. Denison, R. Jagenburg, 1997, Alcohol and alcoholism.

Initial pain course and delay to hospital admission in relation to myocardial infarct size.

J. Herlitz, S. Jern, S. Holmberg, 1988, Heart & lung : the journal of critical care.

Differential immediate‐early gene responses to shear stress and intraluminal pressure in intact human conduit vessels

S. Jern, R. Doroudi, L. Gan, 2000, FEBS letters.

Comparison of cardiovascular risk profile between male employees of two automotive companies in France and Sweden

A. Simon, P. Björntorp, J. Levenson, 1997, European Journal of Epidemiology.

Dependence of Proximal GC Boxes and Binding Transcription Factors in the Regulation of Basal and Valproic Acid-Induced Expression of t-PA

S. Jern, L. Karlsson, E. Ulfhammer, 2016, International journal of vascular medicine.

Histone Deacetylase Inhibitor Treatment Increases Coronary t-PA Release in a Porcine Ischemia Model

G. Johansson, S. Jern, P. Larsson, 2014, PloS one.

A New Biomechanical Perfusion System for ex vivo Study of Small Biological Intact Vessels

S. Jern, L. Karlsson, M. Andersson, 2005, Annals of Biomedical Engineering.

Relation of central hemodynamics to obesity and body fat distribution.

P. Björntorp, L. Hansson, S. Jern, 1992, Hypertension.

P2 Receptor Expression Profiles in Human Vascular Smooth Muscle and Endothelial Cells

D. Erlinge, T. Gudbjartsson, S. Moses, 2002, Journal of cardiovascular pharmacology.

Estrogen and progestagen modify the hemodynamic response to mental stress in young women

L. Hansson, S. Jern, I. Milsom, 1996, Acta obstetricia et gynecologica Scandinavica.

Long-term stability of blood pressure and pressor reactivity to mental stress in borderline hypertension.

S. Jern, A. Bergbrant, U. Wall, 1995, American journal of hypertension.

Effects of insulin on vascular responses to mental stress and norepinephrine in human forearm.

S. Jern, 1994, Hypertension.

Infusion of Epinephrine Augments Pressor Responses to Mental Stress

S. Jern, M. Pilhall, C. Jem, 1991, Hypertension.

Questionnaire for the Assessment of Symptoms and Psychological Effects in Cardiovascular Therapy (the ASPECT Scale).

S. Jern, 1990, Scandinavian journal of primary health care. Supplement.

Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point.

M. Nieminen, P. Okin, M. Viitasalo, 2001, Journal of the American College of Cardiology.

Uridine triphosphate (UTP) is released during cardiac ischemia.

J. Harnek, D. Erlinge, Goran Olivecrona, 2005, International journal of cardiology.

Hypothermia in cardiogenic shock reduces systemic t-PA release

D. Erlinge, S. Jern, L. M. Hultén, 2011, Journal of Thrombosis and Thrombolysis.

In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study

P. Okin, R. Devereux, S. Kjeldsen, 2007, Hypertension.

Influence of TNF-alpha and biomechanical stress on endothelial anti- and prothrombotic genes.

K. Glise, S. Jern, L. Karlsson, 2009, Biochemical and biophysical research communications.

Rapid and specific hypomethylation of enhancers in endothelial cells during adaptation to cell culturing

H. Carén, S. Jern, P. Larsson, 2016, Epigenetics.

Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.

P. Okin, R. Devereux, S. Kjeldsen, 2001, American journal of hypertension.

Enhanced levels of tissue-type plasminogen activator in borderline hypertension.

C. Jern, S. Jern, A. Bergbrant, 1995, Hypertension.

Effect of shear stress, statins and TNF-α on hemostatic genes in human endothelial cells.

S. Jern, E. Ulfhammer, P. Larsson, 2012, Biochemical and biophysical research communications.

Heterogeneous glycosylation patterns of human PAI-1 may reveal its cellular origin.

H. Brogren, C. Sihlbom, S. Jern, 2008, Thrombosis research.

Association of left bundle branch block with left ventricular structure and function in hypertensive patients with left ventricular hypertrophy: the LIFE study

M. Nieminen, P. Okin, R. Devereux, 2004, Journal of Human Hypertension.

Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study.

M. Nieminen, P. Okin, M. Viitasalo, 2003, American heart journal.

Is hypertension a risk factor for cancer?

T. Hedner, S. Jern, L. Hansson, 1997, Blood pressure.

Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study

M. Nieminen, R. Devereux, S. Julius, 2004, Journal of Human Hypertension.

Comparison of cardiovascular risk profile between male employees of two automotives companies in France and Sweden. The Coeur Project Group.

A. Simon, P. Björntorp, J. Levenson, 1997, European journal of epidemiology.

Effects of two complex hemodynamic stimulation profiles on hemostatic genes in a vessel-like environment.

S. Jern, L. Karlsson, E. Ulfhammer, 2008, Endothelium : journal of endothelial cell research.

Regulation of local availability of active tissue‐type plasminogen activator in vivo in man

C. Jern, S. Jern, T. Gudnason, 2004, Journal of thrombosis and haemostasis : JTH.

Endothelium-dependent vasodilation and tissue-type plasminogen activator release in borderline hypertension.

C. Jern, S. Jern, L. Selin-Sjögren, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Impaired glucose tolerance at five-year follow-up of young men with borderline hypertension.

S. Jern, A. Bergbrant, U. Wall, 1996, Blood pressure.

Pathophysiology of cardiovascular structural changes in hypertension.

S. Jern, 1992, Clinical and experimental hypertension. Part A, Theory and practice.

Calcium antagonists--looking stronger by the day.

T. Hedner, S. Jern, L. Hansson, 1997, Blood pressure.

Plasminogen activator inhibitor 1 expression in platelets is not influenced by the 4G/5G promoter polymorphism.

H. Brogren, S. Jern, L. Karlsson, 2008, Thrombosis research.

Circulatory aspects of hypertension. Hypertension seminars at Ostra Hospital, Göteborg, Sweden.

R. Eggertsen, L. Hansson, L. Andrén, 2009, Acta medica Scandinavica.

Contractions in human coronary bypass vessels stimulated by extracellular nucleotides.

D. Erlinge, T. Gudbjartsson, S. Jern, 2003, The Annals of thoracic surgery.

TNF‐α mediated suppression of tissue type plasminogen activator expression in vascular endothelial cells is NF‐κB‐ and p38 MAPK‐dependent

S. Jern, M. Bokarewa, A. Tarkowski, 2006, Journal of thrombosis and haemostasis : JTH.

Behavioral reactivity in spontaneously hypertensive rats

K. Larsson, S. Carlsson, S. Jern, 1985, Physiology & Behavior.

The enigmatic association of birth weight with blood pressure.

T. Hedner, S. Jern, L. Hansson, 1997, Blood pressure.

'Polycythaemia of stress' in subjects with Type A and Type B behaviour patterns.

C. Jern, S. Jern, H. Wadenvik, 1991, Journal of psychosomatic research.

Effects of psychosocial stress on the fibrinolytic system in man

B. Risberg, E. Eriksson, S. Jern, 1990 .

Valproic acid selectively increases vascular endothelial tissue‐type plasminogen activator production and reduces thrombus formation in the mouse

R. Medcalf, S. Jern, S. Jackson, 2016, Journal of thrombosis and haemostasis : JTH.

Histone Deacetylase Inhibition Enhances Tissue Plasminogen Activator Release Capacity in Atherosclerotic Man

E. Omerovic, S. Jern, E. Ulfhammer, 2015, PloS one.

Profibrinolytic Effect of the Epigenetic Modifier Valproic Acid in Man

S. Jern, P. Larsson, N. Bergh, 2014, PloS one.

Histone deacetylase inhibitors stimulate tissue-type plasminogen activator production in vascular endothelial cells

S. Jern, L. Karlsson, E. Ulfhammer, 2013, Journal of Thrombosis and Thrombolysis.

Cardiac Sympathetic Nerve Stimulation Triggers Coronary t-PA Release

C. Jern, S. Jern, J. Björkman, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Preparations and Experimental Protocols Experiment I : Stimulation of Cardiac Sympathetic Nerves

C. Jern, S. Jern, J. Björkman, 2003 .

Association of left bundle branch block with cardiovascular morbidity and mortality in hypertensive patients with left ventricle hypertrophy: the life study

M. Nieminen, P. Okin, R. Devereux, 2004 .

What is happening to blood pressure?

T. Hedner, S. Jern, L. Hansson, 1996, Blood pressure.

Impaired Capacity for Stimulated Fibrinolysis in Primary Hypertension Is Restored by Antihypertensive Therapy

S. Jern, E. Ulfhammer, T. Hrafnkelsdóttir, 2006, Hypertension.

Cardiovascular responses to stress in young hypertensive women.

L. Hansson, C. Jern, S. Jern, 1992, Journal of hypertension.

Impact of Diabetes Mellitus on Regression of Electrocardiographic Left Ventricular Hypertrophy and the Prediction of Outcome During Antihypertensive Therapy The Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study Hypertension

P. Okin, S. Kjeldsen, S. Julius, 2006 .

An Experimental Multiple-Organ Model for the Study of Regional Net Release/Uptake Rates of Tissue-type Plasminogen Activator in the Intact Pig

C. Jern, O. Winsö, S. Jern, 1997, Thrombosis and Haemostasis.

Left ventricular hypertrophy--should it be looked for in all hypertensive patients?

T. Hedner, S. Jern, L. Hansson, 1996, Blood pressure.

Effects of IL-1beta and IL-6 on tissue-type plasminogen activator expression in vascular endothelial cells.

S. Jern, M. Bokarewa, L. Karlsson, 2008, Thrombosis research.

The impaired fibrinolytic capacity in hypertension is unaffected by acute blood pressure lowering

S. Jern, M. Carlström, O. Saluveer, 2011, Journal of Thrombosis and Thrombolysis.

Elevated intraluminal pressure inhibits vascular tissue plasminogen activator secretion and downregulates its gene expression.

S. Jern, R. Doroudi, L. Gan, 2000, Hypertension.

Tissue-type Plasminogen Activator –7,351C/T Enhancer Polymorphism Is Associated with a First Myocardial Infarction

J. Jansson, C. Jern, S. Jern, 2002, Thrombosis and Haemostasis.

Identification of Eight Novel Single-Nucleotide Polymorphisms at Human Tissue-type Plasminogen Activator (t-PA) Locus: Association with Vascular t-PA Release In Vivo

C. Jern, S. Jern, U. Wall, 2000, Thrombosis and Haemostasis.

The role of the platelet pool of Plasminogen Activator Inhibitor-1 in well-controlled type 2 diabetes patients

P. Jansson, H. Brogren, S. Jern, 2022, PloS one.

Short-Term Safety and Tolerability of Double-Dose Salmeterol/Fluticasone Propionate in Adult Asthmatic Patients

L. Adolfsson, Michael Lundgren, S. Jern, 2005, Clinical drug investigation.

Extracellular Nucleotides ATP and UTP Induce a Marked Acute Release of Tissue-type Plasminogen Activator In Vivo in Man

D. Erlinge, S. Jern, T. Hrafnkelsdóttir, 2001, Thrombosis and Haemostasis.

Impaired capacity for endogenous fibrinolysis in essential hypertension

C. Jern, S. Jern, U. Wall, 1998, The Lancet.

Pulmonary embolism and deep vein thrombosis—comorbidities and temporary provoking factors in a register‐based study of 1.48 million people

A. Rosengren, S. Jern, P. Hansson, 2022, Research and practice in thrombosis and haemostasis.

Platelets Retain High Levels of Active Plasminogen Activator Inhibitor 1

H. Brogren, S. Jern, J. Deinum, 2011, PloS one.

Evaluation of Mood and the Effect of Angiotensin-Converting Enzyme Inhibitors

S. Jern, 2012, Drugs.

Fluid Shear Stress Increases the Intra-cellular Storage Pool of Tissue-type Plasminogen Activator in Intact Human Conduit Vessels

C. Jern, S. Jern, R. Doroudi, 2000, Thrombosis and Haemostasis.

Effects of shear stress on eicosanoid gene expression and metabolite production in vascular endothelium as studied in a novel biomechanical perfusion model.

S. Jern, R. Doroudi, L. Gan, 2000, Biochemical and biophysical research communications.

Structural regression of the vasculature during antihypertensive treatment.

S. Jern, R. Sivertsson, 1987, Journal of clinical hypertension.

Evidence of a local mechanism for desmopressin-induced tissue-type plasminogen activator release in human forearm.

C. Jern, S. Jern, L. Tengborn, 1998, Blood.

In Vivo Release of Tissue-Type Plasminogen Activator across the Human Forearm during Mental Stress

C. Jern, S. Jern, L. Selin, 1994, Thrombosis and Haemostasis.

Forearm blood flow responses to neuropeptide Y, noradrenaline and adenosine 5'-triphosphate in hypertensive and normotensive subjects.

D. Erlinge, L. Edvinsson, S. Jern, 2000, Blood pressure.

Quantification of ADP and ATP receptor expression in human platelets

H. Brogren, D. Erlinge, S. Jern, 2003, Journal of thrombosis and haemostasis : JTH.

Defining quality of life in medicine.

I. Wiklund, C. Dahlöf, E. Dimenäs, 1990, Scandinavian journal of primary health care. Supplement.

Temporal regulation of endothelial ET-1 and eNOS expression in intact human conduit vessels exposed to different intraluminal pressure levels at physiological shear stress.

S. Jern, R. Doroudi, L. Gan, 2000, Cardiovascular research.

Response to letter to editor by Jolobe ‘Results have relevance for resolving discrepancies in the approach to population screening’

S. Jern, A. Bergbrant, O. Saluveer, 2009 .

Influence of increased adrenergic activity and magnesium depletion on cardiac rhythm in alcohol withdrawal.

S. Jern, H. Denison, R. Jagenburg, 1994, British heart journal.

Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study

M. Nieminen, P. Okin, R. Devereux, 2008, Journal of hypertension.

Systemic levels and preportal organ release of tissue‐type plasminogen activator are enhanced by PEEP in the pig

C. Jern, G. Johansson, O. Winsö, 1999, Acta anaesthesiologica Scandinavica.

Swedish Isradipine Study in Hypertension: Evaluation of Quality of Life, Safety, and Efficacy

R. Eggertsen, L. Hansson, B. Dahlöf, 1991, Journal of cardiovascular pharmacology.

Prolonged cyclic strain impairs the fibrinolytic system in cultured vascular endothelial cells

S. Jern, L. Karlsson, M. Andersson, 2005, Journal of hypertension.

Editorial: Prediction of insulin resistance

T. Hedner, L. Hansson, S. Jern, 1996 .

Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study.

M. Nieminen, P. Okin, M. Viitasalo, 2001, Journal of hypertension.

Long-term experience with the combination of pindolol and isradipine in essential hypertension

R. Eggertsen, L. Hansson, B. Dahlöf, 1988 .

Unsatisfactory blood pressure control--patient's neglect or doctor's hesitation?

T. Hedner, S. Jern, L. Hansson, 1997, Blood pressure.

High capacity for tissue‐type plasminogen activator release from vascular endothelium in vivo

C. Jern, S. Jern, U. Wall, 1997, Journal of hypertension.

Release of Tissue-Type Plasminogen Activator in Response to Muscarinic Receptor Stimulation in Human Forearm

C. Jern, S. Jern, A. Bergbrant, 1994, Thrombosis and Haemostasis.

Transcutaneous electrical nerve stimulation induces vasodilation in healthy controls but not in refractory angina patients.

C. Mannheimer, S. Jern, B. Biber, 2010, Journal of pain and symptom management.

Regression of Electrocardiographic Left Ventricular Hypertrophy by Losartan Versus Atenolol: The Losartan Intervention For Endpoint reduction in hypertension (LIFE) Study

M. Nieminen, P. Okin, R. Devereux, 2003, Circulation.

The ADP receptor P2Y1 mediates t-PA release in pigs during cardiac ischemia

K. Jacobson, J. Harnek, D. Erlinge, 2007, Journal of Thrombosis and Thrombolysis.

Hemostatic Responses to Mental Stress during the Menstrual Cycle

C. Jern, B. Risberg, E. Eriksson, 1991, Thrombosis and Haemostasis.

On Salt and Treatment Goals in Hypertension: Time for Reappraisal?

T. Hedner, L. Hansson, S. Jern, 1992 .

Cortisol secretion in relation to body fat distribution in obese premenopausal women.

P. Björntorp, P. Mårin, N. Darín, 1992, Metabolism: clinical and experimental.

Increased Mitogenic and Decreased Contractile P2 Receptors in Smooth Muscle Cells by Shear Stress in Human Vessels With Intact Endothelium

D. Erlinge, S. Jern, L. Karlsson, 2003, Arteriosclerosis, thrombosis, and vascular biology.

A New Computerized Biomechanical Perfusion Model for ex vivo Study of Fluid Mechanical Forces in Intact Conduit Vessels

S. Jern, R. Doroudi, L. Gan, 1999, Journal of Vascular Research.

Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients.

B. Dahlöf, B. Karlberg, S. Jern, 1984, British journal of clinical pharmacology.

The issue of quality of life in antihypertensive therapy.

A. Zanchetti, S. Jern, 1993, Journal of human hypertension.

After SHEP, STOP and MRC--new WHO/ISH guidelines for the management of mild hypertension.

T. Hedner, S. Jern, L. Hansson, 1993, Blood pressure.

Gene polymorphism of t-PA is associated with forearm vascular release rate of t-PA.

C. Jern, S. Jern, S Jern, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Dynamic Enhancer Methylation - A Previously Unrecognized Switch for Tissue-Type Plasminogen Activator Expression

H. Carén, S. Jern, E. Ulfhammer, 2015, PloS one.

Impaired myocardial t‐PA release in patients with coronary artery disease

C. Jern, G. Johansson, S. Jern, 2008, Acta anaesthesiologica Scandinavica.

Methodological studies of multiple reference genes as endogenous controls in vascular gene expression studies.

P. Svensson, S. Jern, L. Karlsson, 2005, Endothelium : journal of endothelial cell research.

Normalization of qPCR in platelets – YWHAE a potential genericreference gene

P. Svensson, H. Brogren, D. Erlinge, 2016, Platelets.

Electrocardiographic Strain Pattern and Prediction of New-Onset Congestive Heart Failure in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study

Lauri Toivonen, Lasse Oikarinen, Matti Viitasalo, 2005, Circulation.

Electrocardiographic Strain Pattern and Prediction of Cardiovascular Morbidity and Mortality in Hypertensive Patients

M. Nieminen, P. Okin, M. Viitasalo, 2004, Hypertension.

Correspondence between screening and intra‐arterial blood pressures in young men with borderline hypertension

L. Hansson, S. Jern, A. Bergbrant, 1993, Journal of internal medicine.

Distinct regulation of vascular endothelial growth factor in intact human conduit vessels exposed to laminar fluid shear stress and pressure.

S. Jern, R. Doroudi, L. Gan, 2000, Biochemical and biophysical research communications.

Smoking affects blood pressure.

T. Hedner, S. Jern, S Jern, 1996, Blood pressure.

Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reaction.

T. Hedner, L. Hansson, B. Dahlöf, 1990, Journal of hypertension.

Impact of Diabetes Mellitus on Regression of Electrocardiographic Left Ventricular Hypertrophy and the Prediction of Outcome During Antihypertensive Therapy: The Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study

P. Okin, R. Devereux, S. Kjeldsen, 2006, Circulation.

Changes of Plasma Coagulation and Fibrinolysis in Response to Mental Stress

C. Jern, B. Risberg, E. Eriksson, 1989, Thrombosis and Haemostasis.

Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.

Sverker Jern, Richard B Devereux, Lars H Lindholm, 2006, JAMA.

Role of Histone Acetylation in the Stimulatory Effect of Valproic Acid on Vascular Endothelial Tissue-Type Plasminogen Activator Expression

P. Svensson, R. Medcalf, A. El-Osta, 2012, PloS one.

Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.

P. Okin, R. Devereux, S. Kjeldsen, 2000, Hypertension.

Suppression of endothelial t-PA expression by prolonged high laminar shear stress.

S. Jern, L. Karlsson, E. Ulfhammer, 2009, Biochemical and biophysical research communications.

Disturbed Laminar Blood Flow Causes Impaired Fibrinolysis and Endothelial Fibrin Deposition In Vivo

J. Borén, S. Jern, T. Ny, 2019, Thrombosis and Haemostasis.

Fibrinolytic capacity increases with age in healthy humans, while endothelium-dependent vasodilation is unaffected

K. Swedberg, S. Jern, T. Gudnason, 2003, Thrombosis and Haemostasis.

QRS Duration and QT Interval Predict Mortality in Hypertensive Patients With Left Ventricular Hypertrophy: The Losartan Intervention for Endpoint Reduction in Hypertension Study

Lauri Toivonen, Lasse Oikarinen, Matti Viitasalo, 2004, Hypertension.

Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.

Anne L. Taylor, M. Nieminen, P. Okin, 2002, American journal of hypertension.

Baseline Characteristics in Relation to Electrocardiographic Left Ventricular Hypertrophy in Hypertensive Patients: The Losartan Intervention For Endpoint Reduction (LIFE) in Hypertension Study

P. Okin, R. Devereux, S. Kjeldsen, 2000, Hypertension.

Haematological changes during acute mental stress

C. Jern, S. Jern, H. Wadenvik, 1989, British journal of haematology.

Gene polymorphism of t-PA is associated with forearm vascular release rate of t-PA.

Sverker Jern, Christina Jern, Per Ladenvall, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Regression of Electrocardiographic Left Ventricular Hypertrophy Is Associated with Less Hospitalization for Heart Failure in Hypertensive Patients

P. Okin, R. Devereux, S. Kjeldsen, 2007, Annals of Internal Medicine.

Risk reduction when treating hypertension--are there differences between the various classes of drugs?

T. Hedner, S. Jern, L. Hansson, 1995, Blood pressure.

Intraluminal pressure modulates eicosanoid enzyme expression in vascular endothelium of intact human conduit vessels at physiological levels of shear stress

S. Jern, R. Doroudi, L. Gan, 2002, Journal of hypertension.

Consistency of blood pressure and impact on cardiovascular structure over 20 years in young men

S. Jern, A. Bergbrant, O. Saluveer, 2010, Journal of internal medicine.

Preserved tissue-type plasminogen activator release and endothelium-dependent vasodilation in postmenopausal women with NIDDM.

L. Wilhelmsen, S. Jern, K. Manhem, 2000, Journal of diabetes and its complications.

Impaired Endothelial Release of Tissue-Type Plasminogen Activator in Patients With Chronic Kidney Disease and Hypertension

S. Jern, O. Samuelsson, T. Gudnason, 2004, Hypertension.

Measurement of quality of life

S. Jern, S. Jern, 1988 .

Obesity in adolescent men increases the risk of venous thromboembolism in adult life

K. Torén, A. Rosengren, M. Adiels, 2020, Journal of internal medicine.

Sympathoadrenal Activation and Muscarinic Receptor Stimulation Induce Acute Release of Tissue-Type Plasminogen Activator but not von Willebrand Factor across the Human Forearm

C. Jern, S. Jern, L. Tengborn, 1997, Thrombosis and Haemostasis.

Safety aspects of spinal cord stimulation in severe angina pectoris

L. Augustinsson, C. Mannheimer, S. Jern, 1994, Coronary artery disease.

Differential Global Gene Expression Response Patterns of Human Endothelium Exposed to Shear Stress and Intraluminal Pressure

Erik Ulfhammer, Sverker Jern, Maria Andersson, 2005, Journal of Vascular Research.

Interrelation of cardiac and vascular structure in young men with borderline hypertension.

L. Hansson, S. Jern, A. Bergbrant, 1993, European heart journal.

Ischaemic heart disease and the changes in the QRS and ST segments during exercise: a pilot study with a novel vectorcardiographic system.

S. Jern, M. Říha, M. Pilhall, 1992, Clinical physiology.

Mild hypothermia markedly reduces ischemia related coronary t-PA release

H. Brogren, D. Erlinge, S. Jern, 2010, Journal of Thrombosis and Thrombolysis.

Endothelin in hypertension--a matter ignored or to be ignored?

T. Hedner, S. Jern, L. Hansson, 1994, Blood Pressure.

Impaired capacity for endogenous fibrinolysis in essential

C. Jern, S. Jern, W. Africa, 1998 .

Correction: Histone Deacetylase Inhibition Enhances Tissue Plasminogen Activator Release Capacity in Atherosclerotic Man

E. Omerovic, S. Jern, E. Ulfhammer, 2015, PloS one.

Anesthesia and surgery influences regional net release and uptake rates of tissue‐type plasminogen activator. An experimental study in the intact pig

C. Jern, G. Johansson, O. Winsö, 1997, Acta anaesthesiologica Scandinavica. Supplementum.

Pain assessment by patients and nurses in the early phase of acute myocardial infarction.

J. Herlitz, S. Jern, S. Holmberg, 1987, Journal of advanced nursing.

Changes in the QRS segment during exercise: effects of acute beta-blockade with propranolol.

S. Jern, M. Říha, M. Pilhall, 1993, Clinical physiology.

Effects of Acute Carbohydrate Administration on Central and Peripheral Hemodynamic Responses to Mental Stress

S. Jern, S Jern, 1991, Hypertension.

Local tissue‐type plasminogen activator release in patients with ischemic stroke

C. Blomstrand, C. Jern, S. Jern, 2007, Journal of thrombosis and haemostasis : JTH.

Comparison of cardiovascular risk profile between male employees of two automotive companies in France and Sweden

P. Mårin, S. Jern, L. Kumlin, 1997, European Journal of Epidemiology.